STABLE COMPOSITIONS OF CYTOMEGALOVIRUS Russian patent published in 2023 - IPC C12N7/00 C12N7/04 A61K39/245 A61K47/00 

Abstract RU 2800361 C2

FIELD: biotechnology.

SUBSTANCE: composition for generating an immune response against cytomegalovirus (CMV) is described. The composition contains live attenuated CMV, which is conditionally defective in replication, and contains (a) a pentameric gH complex, including UL128, UL130, UL131, gH and gL; and (b) a nucleic acid encoding a fusion protein consisting of an essential protein and a destabilizing protein, where the essential protein is selected from the group consisting of IE1/2, UL51, UL52, UL79 and UL84.

EFFECT: invention expands the arsenal of means for generating an immune response against cytomegalovirus.

43 cl, 30 dwg, 16 tbl, 15 ex

Similar patents RU2800361C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODIES TO PCSK-9, AND ITS USE 2018
  • Tian, Chenmin
  • Li, Hao
  • Liu, Xun
RU2782792C2
PHARMACEUTICAL COMPOSITIONS FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY 2019
  • Yang, Mark
  • Buser, Claudia
  • Perez-Ramirez, Bernardo
  • Trierweiler, Grant
  • Benjwal, Sangeeta
RU2826120C2
INDUCIBLE CHIMERIC CYTOKINE RECEPTORS 2019
  • Nager, Endryu Ross
  • Park, Spenser
  • Chaparro Riggers, Khaver Fernando
  • Lin, Redzhina Tszyunkhuej
  • Van Blarkom, Tomas Dzhon
RU2826155C2
PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-5 ANTIBODY, AND USE THEREOF 2020
  • U, Tintin
  • Li, Khao
  • Lyu, Syun
  • Tao, Vejkan
RU2824390C2
COMBINED FORMULATIONS OF ANTI-LAG3 ANTIBODY AND ANTI-PD-1 ANTIBODY 2019
  • Antoshchuk, Valentin
  • Desai, Priti, Dzh.
  • Krishnamakhari, Jogita
  • Sangani, Sakhil, S.
RU2822192C2
STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENT METHODS 2012
  • Sharma Manodzh K.
  • Narasimkhan Chakravarti Nachu
  • Gergich Kevin Dzhejms
  • Kang Soonmo Piter
RU2563346C2
LYOPHILISED DNA COMPOUNDS FOR INCREASED PLASMID DNA EXPRESSION 2009
  • Kim Dzong-Mook
  • Kim Sudzeong
  • Khan Voong
  • Joo Vonsun
RU2470995C2
PHARMACEUTICAL COMPOSITION OF THE FUSION PROTEIN OF THE TRANSFORMING GROWTH FACTOR BETA RECEPTOR AND ITS APPLICATION 2019
  • Tyan, Chenmin
  • Li, Khao
  • Lyu, Syun
RU2791683C2
PHARMACEUTICAL COMPOSITION BASED ON ANTIBODIES AGAINST CD40 AND APPLICATION THEREOF 2019
  • Yang, Jianjian
  • Li, Hao
  • Liu, Xun
  • Jiang, Jiahua
RU2778572C1
STABLE COMPOSITIONS OF ANTI-TIGIT ANTIBODIES, INDIVIDUALLY AND IN COMBINATION WITH ANTIBODIES AGAINST PROGRAMMED DEATH RECEPTOR 1 (PD-1), AND METHODS OF THEIR USE 2018
  • De, Arnab
  • Narasimkhan, Chakravarti Nachu
RU2820576C2

RU 2 800 361 C2

Authors

Medi, Muneesvara Babu

Devis, Kharrison Bredford

Chen, Lorentso, Kh.

Isopi, Linn Enn

Blyu, Dzheffri Tomas

Piksli, Khajdi Dzhoan

Grin-Treksler, Erin, Dzh.

Dates

2023-07-20Published

2018-10-29Filed